Minimal access, or keyhole, surgery delivers acknowledged clinical benefits. Those benefits include less trauma, reduced scarring, faster recovery times and lower costs for healthcare providers. 

However, minimal access surgery is not available to everyone because the techniques are hard to master, the training time long and the procedure physically demanding to perform. 

Robot-assisted surgery can offer all the benefits of manual minimal access surgery while crucially making life easier for the surgeon, extending their careers, and at an affordable cost. 


To make the benefits of minimal access surgery universally accessible, the system must be:

  • Versatile, increasing the range of procedures supported, including head and neck, upper GI, colorectal, and bariatric
  • Affordable, optimising whole life costs for all healthcare providers and insurers
  • State of the art, incorporating wristed 5mm instruments, restoring a sense of touch to surgeons
  • Easy for surgeons to adopt with minimal additional training
  • Supportive of all common port placements and surgical techniques
  • Design-optimised for ease of use by all surgical team members
  • Compact and light-weight, easy to install, manoeuvre and set up
  • Modular and adaptable to all operating environments
  • Safe, reflecting the best practice safety protocols and procedures

CMR is developing a next-generation robotic system to meet all of these needs, expand the market and make the benefits of minimal access surgery universally accessible and affordable.


CMR’s goal is to increase the volume and range of surgical procedures performed robotically and to deliver an affordable solution for healthcare providers. Our commercial model will ultimately reduce the total cost of ownership offered by alternative solutions by more than 50% and will be cost comparable with equivalent manual keyhole procedures.

Surgical Robotics

Surgical robotics, robotic surgery, and robotically-assisted surgery are terms for technological developments that use robotic systems to aid surgical procedures. Robotically-assisted surgery was initially developed in the 1980s to overcome the limitations of minimal access (also known as keyhole or minimally-invasive) surgery and to enhance the capabilities of surgeons performing open surgery.

In the case of robotically-assisted minimal access surgery, instead of directly holding the instruments, the surgeon uses alternative methods to control the instruments; either through computer control or using direct telemanipulation, the method followed by CMR.

The current market for surgical robotics is dominated by hysterectomy and prostatectomy procedures performed in the United States. CMR aims to expand the market by significantly increasing the range of procedures performed and reducing the capital and operational cost of each procedure.


The CMR robotic system has been conceived, designed and built specifically to support the demands of modern surgery. Throughout the design process CMR has involved the broader surgical community.

We have recruited all the competencies necessary to meet the demands of medical device development, enabling the business to follow Good Manufacturing Practice and Risk Management protocols as required by the FDA and other Notified Bodies thereby ensuring that the system is effective and as safe as possible.

Technology and Intellectual Property

CMR presently has over 80 patent applications filed in the United Kingdom or under the Patent Cooperation Treaty which protect the fundamental disruptive technologies behind our product.